Balentine LLC Abiomed Inc Transaction History

Balentine LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$255.22 - $317.0 $765 - $951	-3 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $424 - $771	3 New	3 $1,000
Q1 2020 May 18, 2020	SELL	$130.51 - $196.01 $1,435 - $2,156	-11 Closed	0 $0
Q4 2019 Sep 02, 2020	BUY	$159.31 - $223.54 $477 - $670	3 Added 37.5%	11 $2,000
Q3 2019 Nov 15, 2019	BUY	$175.89 - $279.23 $1,407 - $2,233	8 New	8 $1,000
Q1 2018 May 16, 2018	SELL	$192.49 - $295.85 $192,490 - $295,850	-1,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $84,390 - $99,870	-500 Reduced 33.33%	1,000 $187,000
Q3 2017 Nov 15, 2017	BUY	$145.39 - $168.6 $218,084 - $252,900	1,500	1,500 $253,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.